Jiarui Yao

4PUBLICATIONS
28CO-AUTHORS
Molecular targetsChemotherapyInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 25, 2025
Multiomics and Single-Cell Insights Reveal a Lysophosphatidic Acid-Mediated Resistant Mechanism to Third-generation EGFR-TKI in Non-Small Cell Lung Cancer.

Ruyun Gao, Ning Lou, Sheng Yang

|Feb 24, 2025
Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study.

Yuquan Qian, Le Tang, Jiarui Yao

|Dec 11, 2024
A Novel IgG-IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules.

Rongrong Luo, Xiying Li, Ruyun Gao

|Mar 01, 2023
High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma.

Rongrong Luo, Pei Zhong, Xiying Li

Pageof 1